Gastrointestinal Manifestations of the COVID-19: A Systematic Review and Meta-Analysis with 111 studies

Introduction/aims: Since the start of a pandemic from Wuhan, China in 2019, there is tremendous attention in the COVID-19 manifestation. One of the most important COVID-19 clinical presentations is gastrointestinal symptoms. The current systematic review study aims to focus on the implication of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of biostatistics and epidemiology 2021-12, Vol.7 (4)
Hauptverfasser: Saber Soltani, Armin Zakeri, Iraj Pakzad, Alireza Tabibzadeh, Amir Mohammad Zakeri, Milad Zandi, Sara Akhavan Rezayat, Mehrzad Jafarzadeh, Parinaz Khalkhali Asl, Arghavan Zebardast, Yousef Erfani, Ramin Shahbahrami, Reza Pakzad, Pooneh Malekifar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction/aims: Since the start of a pandemic from Wuhan, China in 2019, there is tremendous attention in the COVID-19 manifestation. One of the most important COVID-19 clinical presentations is gastrointestinal symptoms. The current systematic review study aims to focus on the implication of the gastrointestinal tract in patients infected with SARS-CoV-2. Methods: For that we searched literature in MEDLINE, Scopus, Web of Science, and Embase. Also, the medRxiv was searched for preprints. The search was performed by using the following keywords "Covid-19", "Coronavirus", "SARS-CoV-2 infection", "SARS-CoV-2", "Gastrointestinal", "Gastrointestinal Tract", "digestive system". All the studies were conducted based on the PRISMA criteria. Results: Of 3028 retrieved documents, 111 studies with 21126 COVID-19 cases were included. The prevalence of any Gastrointestinal symptoms was 17.22% (14.48 to 20.13). The prevalence of diarrhea was 13.75% (12.07 to 15.44), anorexia 27.41% (21.53 to 33.29) and Nausea/vomiting 8.11% (6.87 to 9.35). Furthermore, the prevalence of other symptoms in our current study was fever 76.70% (73.42 to 79.83), cough 58.07% (54.59 to 61.52) and dyspnea/shortness of breath 24.63% (20.06 to 29.48). According to meta-regression results, age (p: 0.027) and fever (p
ISSN:2383-4196
2383-420X